Brief: Baudax Bio Says Chairman Alfred Altomari Notified Of His Intent To Resign From Board Immediately Following 2022 Annual Meeting
31/03/2022 22:15
March 31 (Reuters) - Baudax Bio Inc BXRX.O :
* BAUDAX BIO INC - CHAIRMAN ALFRED ALTOMARI NOTIFIED OF HIS
INTENT TO RESIGN FROM BOARD IMMEDIATELY FOLLOWING 2022 ANNUAL
MEETING
* BAUDAX BIO INC - INTENDS TO APPOINT A NEW CHAIRMAN OF
BOARD
PRIOR TO EFFECTIVENESS OF MR. ALTOMARI'S RESIGNATION
* BAUDAX BIO INC - EFFECTIVE UPON RESIGNATION OF MR.
ALTOMARI,
SIZE OF BOARD WILL BE REDUCED FROM SEVEN DIRECTORS TO SIX
DIRECTORS
Further company coverage: BXRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer